IP Library Granted Patent US 7,858,741
Granted Patent B2
US 7,858,741 · App. 12/367,374 · Granted Dec 28, 2010

Stabilization of the collagen triple helix by O-methylation of hydroxyproline residues

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,858,741
App. No.
12/367,374
Granted
Dec 28, 2010
Kind
B2
Abstract

This invention relates to a collagen polypeptide comprising a tripeptide motif having the formula (ProYaaGly) n , where Yaa is an O-methylated amino acid residue and “n” is the number of motif repeats. Preferred O-methylated amino acid residues at the Yaa position include (2S,4R)-4-methoxyproline. Other suitable amino acid residues at that position include O-mono or O-di-halogenated methylproline. Also, disclosed is a method of making a synthetic or a semi-synthetic collagen polypeptide molecule having increased stability relative to natural collagen. The strengthened collagen molecules are suitable for use in biomaterials for the medical field or in leather-related products prepared by the tanning industry.

Claims (28)

1. An isolated collagen polypeptide comprising a tripeptide having the formula:

(Pro-Yaa-Gly) n ,

where Yaa is any O-methylated amino acid residue, and

“n” is a positive integer.

2. The polypeptide of claim 1 , wherein Yaa is an O-methylated hydroxyproline.

3. The polypeptide of claim 1 , wherein Yaa is (2S,4R)-4-methoxyproline (Mop).

4. The polypeptide of claim 1 , wherein Yaa is an O-mono-or O-dihalogenated methylproline.

5. The polypeptide of claim 1 , wherein Yaa is selected from a member of the group consisting of O-monofluoromethylproline, O-difluoromethylproline, O-monochloromethylproline, and O-dichloromethylproline.

6. The polypeptide of claim 1 , wherein “n” is at least 3.

7. The polypeptide of claim 1 , wherein “n” is at least 7.

8. The polypeptide of claim 1 , wherein “n” is at least 10.

9. The polypeptide of claim 1 , wherein “n” is between 3 and 300.

10. The polypeptide of claim 1 , wherein the polypeptide is obtained from naturally occurring collagen that is covalently modified at the Yaa position or from de novo synthesized collagen.

11. An isolated collagen polypeptide comprising a tripeptide having the formula (ProMopGly) 10 .

12. A method of making a semi-synthetic collagen, the method comprising the steps of:

providing a natural collagen polypeptide, wherein the polypeptide comprises tripeptides of the formula: (Pro-Yaa-Gly) n , and wherein Yaa is hydroxyproline and “n” is a positive integer;

covalently modifying the hydroxyproline of the natural collagen polypeptide using a methylation reagent to make a semi-synthetic collagen having an O-methylated hydroxyproline at the Yaa position, such that the semi-synthetic collagen has increased stability relative to natural collagen.

13. The method of claim 12 , wherein the amino acid at the Yaa position is (2S,4R)-4-methoxyproline (Mop).

14. The method of claim 12 , wherein “n” is between 3 and 300.

15. A semi-synthetic O-methylated collagen manufactured by the process of claim 12 .

16. The method of claim 12 , wherein the amino acid at the Yaa position is an O-mono- or O-dihalogenated methylproline.

17. A method of making synthetic collagen, the method comprising the steps of:

providing a de novo synthesized collagen polypeptide, wherein the polypeptide comprises tripeptides of the formula: (Pro-Yaa-Gly) n , wherein “n” is a positive integer;

covalently modifying the Yaa position of the collagen polypeptide using a methylation reagent to make collagen having an O-methylated amino acid at the Yaa position, such that the modified synthetic collagen has increased stability relative to natural collagen.

18. The method of claim 17 , wherein the O-methylated amino acid is O-methylated hydroxyproline.

19. The method of claim 17 , wherein the O-methylated amino acid is (2S,4R)-4-methoxyproline (Mop).

20. The method of claim 17 , wherein “n” is between 3 and 300.

21. The method of claim 17 , wherein the amino acid at the Yaa position is an O-mono- or O-dihalogenated methylproline.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 23, 2010
From: UNIVERSITY OF WISCONSIN MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024736/0307 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2009
From: RAINES, RONALD T.; KOTCH, FRANK
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 022926/0688 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Feb 23, 2009
From: UNIVERSITY OF WISCONSIN MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022293/0448 →
Continuity (2)
Provisional Application 6102667400 · Feb 6, 2008
Related Publication 20090264626A1 · Oct 22, 2009